Cargando…
Drug development for Autism Spectrum Disorder (ASD): Progress, challenges, and future directions
In 2017, facing lack of progress and failures encountered in targeted drug development for Autism Spectrum Disorder (ASD) and related neurodevelopmental disorders, the ISCTM with the ECNP created the ASD Working Group charged to identify barriers to progress and recom-mending research strategies for...
Autores principales: | McCracken, James T., Anagnostou, Evdokia, Arango, Celso, Dawson, Geraldine, Farchione, Tiffany, Mantua, Valentina, McPartland, James, Murphy, Declan, Pandina, Gahan, Veenstra-VanderWeele, Jeremy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10062405/ https://www.ncbi.nlm.nih.gov/pubmed/34158222 http://dx.doi.org/10.1016/j.euroneuro.2021.05.010 |
Ejemplares similares
-
Large multicenter randomized trials in autism: key insights gained from the balovaptan clinical development program
por: Jacob, Suma, et al.
Publicado: (2022) -
Effects of Metformin on Spatial and Verbal Memory in Children with ASD and Overweight Associated with Atypical Antipsychotic Use
por: Aman, Michael G., et al.
Publicado: (2018) -
Editorial: Precision medicine approaches for heterogeneous conditions such as autism spectrum disorders (The need for a biomarker exploration phase in clinical trials - Phase 2m)
por: Beversdorf, David Q., et al.
Publicado: (2023) -
Translation in fragile X: no home runs in the first at-bat
por: Veenstra-VanderWeele, Jeremy
Publicado: (2017) -
Predictability modulates neural response to eye contact in ASD
por: Naples, Adam J., et al.
Publicado: (2022)